Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$1.27 - $1.75 $5,270 - $7,262
-4,150 Reduced 10.48%
35,447 $56,000
Q4 2023

Feb 02, 2024

SELL
$0.89 - $1.41 $356 - $564
-400 Reduced 1.0%
39,597 $53,000
Q3 2023

Nov 03, 2023

BUY
$1.08 - $1.85 $43,196 - $73,994
39,997 New
39,997 $56,000
Q1 2023

May 15, 2023

BUY
$0.88 - $2.19 $616 - $1,533
700 Added 1.63%
43,633 $46,000
Q4 2022

Feb 13, 2023

SELL
$1.27 - $2.26 $1,143 - $2,033
-900 Reduced 2.05%
42,933 $65,000
Q3 2022

Nov 14, 2022

SELL
$1.41 - $2.79 $2,291 - $4,533
-1,625 Reduced 3.57%
43,833 $93,000
Q2 2022

Aug 15, 2022

BUY
$1.15 - $2.53 $14,420 - $31,726
12,540 Added 38.09%
45,458 $60,000
Q1 2022

May 16, 2022

BUY
$1.91 - $3.98 $1,337 - $2,786
700 Added 2.17%
32,918 $69,000
Q4 2021

Jan 26, 2022

SELL
$3.53 - $5.5 $8,168 - $12,727
-2,314 Reduced 6.7%
32,218 $120,000
Q3 2021

Nov 10, 2021

SELL
$4.99 - $6.55 $31,936 - $41,920
-6,400 Reduced 15.64%
34,532 $172,000
Q2 2021

Jul 29, 2021

BUY
$6.24 - $8.22 $255,415 - $336,461
40,932 New
40,932 $267,000
Q1 2021

May 14, 2021

SELL
$6.74 - $10.95 $277,229 - $450,395
-41,132 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$3.75 - $10.56 $153,806 - $433,118
41,015 Added 35055.56%
41,132 $420,000
Q3 2020

Nov 02, 2020

SELL
$3.5 - $6.2 $116,812 - $206,925
-33,375 Reduced 99.65%
117 $117,000
Q3 2020

Nov 02, 2020

SELL
$3.5 - $6.2 $14,910 - $26,412
-4,260 Reduced 11.28%
33,492 $117,000
Q2 2020

Jul 30, 2020

BUY
$2.16 - $5.46 $8,670 - $21,916
4,014 Added 11.9%
37,752 $188,000
Q1 2020

Apr 14, 2020

BUY
$1.46 - $7.19 $49,257 - $242,576
33,738 New
33,738 $115,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $233M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Magnolia Capital Advisors LLC Portfolio

Follow Magnolia Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnolia Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnolia Capital Advisors LLC with notifications on news.